As Walgreens exits Wall Street after 98 years, its new owners face a daunting turnaround. Will a renewed focus on its ...

Disgraced Theranos founder Elizabeth Holmes is throwing her support behind a new medical startup — despite currently serving a federal prison term stemming from her previous biotech venture ...

Felonious Theranos fraudster Elizabeth Holmes has launched another appeal of her conviction and sentence, claiming that a three-judge panel that shot down her first appeal in February was confused ...

Theranos founder Elizabeth Holmes has lost her appeal of her fraud conviction. A three-judge panel of the U.S. Court of Appeal for the Ninth Circuit on Monday upheld lower court rulings finding ...

Get ready for some fabulous deals for when you're on the go, your beauty routine and in the kitchen ... Recommended Videos Holmes was CEO throughout Theranos’ turbulent 15-year history, claimed ...

Elizabeth Holmes, the founder and CEO of health technology company Theranos, was found guilty of wire fraud and conspiring to commit wire fraud in January. The story of Holmes and her company ...

According to reporter John Carreyrou, who first broke the Theranos story in the Wall Street ... Liz embraced the frenetic beauty of it, and we often reminisce about how it was the favorite place ...

December 2014: Theranos has raised $400 million Theranos has raised more than $400 million, according to a profile of the company and Holmes by The New Yorker. It counts Oracle’s Larry Ellison ...

Prosecutors say Ramesh Balwani worked hand in hand with Elizabeth Holmes, the Theranos chief executive, who was convicted of four counts of fraud. By Erin Woo and Erin Griffith SAN JOSE ...

Count President Joe Biden among the political elites who fell under the spell of Theranos and its founder Elizabeth Holmes, the former Silicon Valley star who was convicted of defrauding investors ...

Elizabeth Holmes, the founder and chief executive of the medical device company Theranos, was convicted Monday on multiple counts of defrauding investors following a four-month trial in federal ...